[Update on current care guidelines. Prolonged epileptic attack].
Kälviäinen
Reeta
R
Autti-Rämö
Ilona
I
Eriksson
Kai
K
Häppölä
Olli
O
Keränen
Tapani
T
Kuoppala
Jaana
J
Kurola
Jouni
J
Kuusela
Anna-Leena
AL
Mervaala
Eero
E
Salmi
Tapani
T
Tallgren
Minna
M
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003975:Diazepam / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D004632:Emergency Medical Services; D005260:Female; D005387:Finland; D006801:Humans; D007262:Infusions, Intravenous; D008140:Lorazepam / Q000008:administration & dosage; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D010634:Phenobarbital / Q000008:administration & dosage; D010672:Phenytoin / Q000008:administration & dosage; D018570:Risk Assessment; D012720:Severity of Illness Index; D013226:Status Epilepticus / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
D000927:Anticonvulsants; D010672:Phenytoin; D008140:Lorazepam; D003975:Diazepam; D010634:Phenobarbital